Elevate Healthcare

Independent

Address

930 Harvest Drive, Suite 430

Blue Bell, Pennsylvania 19422

Web Address

https://elevatehc.com

Year Founded

2015

Page Turners

View Interactive Story

This year’s interactive offering allows the industry to flip through the pages and see how your agency’s story unfolds.

Storycast

Full-time Employees

Number of Clients

North American Revenue 2021

Full-time Employees 2021

Number of clients 2021

Offices

North America

Locations

Blue Bell, PA

Executives & Senior Management

Lorna Weir

Managing Partner

Frank X. Powers

Managing Partner

Barry Schmader

Chief Creative Officer

Senior Management

Lorna Weir Managing Partner

Frank X. Powers Managing Partner

Barry Schmader Chief Creative Officer

Lisa Tamborello Chief Talent Officer

Agency 100 Book Cover

Capabilities/Services Offered

Professional OTC Direct Marketing Med-Tech Data/Analytics Digital

New Services

CX : Customer Experience—the Customer Experience (CX) practice sits at the intersection of Design and Strategy at the agency.

Client Roster

Alexza Pharmaceuticals (Corporate, Staccato OBT) Aspen Green (Corporate) Biofrontera (Ameluz, Xepi) Depuy Synthes Joint Reconstruction (Attune, Corporate, VELYS Digital Surgery, Kincise , Anterior Advantage Hospital Marketing, VELYS Robot, VELYS Hip Navigation, VELYS Patient Path, VELYS Insights, New BioMaterial for Orthpaedics, Johnson & Johnson Institute) DePuy Synthes Trauma (ASC Capabilities, Continuous Compression Implants, FIBULINK, Foot & Ankle, MAXFRAME Autostrut, Plates & Screws, Radial Head Replacement System, Universal Small Fragment System, Upper Extremities Franchise) Mitek Sports Medicine (MONOVISC, PEAK PRP System, ORTHOVISC) EyePoint Pharmaceuticals (DEXYCU, YUTIQ) Eyevance Pharmaceuticals (Flarex, TobraDex ST, Zerviate) Foundation Fighting Blindness (Corporate) Galen US (SYNERA) Grifols (Hypermunes, HyperRAB, Td Vax) Joerns Healthcare (Corporate, Connexio) Johnson & Johnson (Lung Cancer Initiative) LivaNova (VNS Therapy) Medexus USA (Rasuvo , Treosulfan) Mycovia Pharmaceuticals (Corporate, New Product Launch) NORD (Corporate) Recordati Rare Disease (Signifor LAR, Isturisa) Sentynl Therapeutics (Corporate, New Product Launch) Shield Therapeutics (Accrufer) Thea Pharmaceuticals (Corporate, New Product Launch)

Growth

2021 Growth from Existing Clients

70%

2021 Growth from New Clients

30%

Trends and Challenges

Diversity and inclusion Talent acquisition/retention Managing growth Getting an audience, virtually or otherwise, with HCPs Keeping up with pace of innovation Procurement-related issues Shrinking pharma budgets Further diversification of services Regulatory concerns Pandemic-related disruptions

Healthcare Marketing Trends

More personalization of communications Need to create more/better content/experiences Heightened focus on payers Increased concern over drug pricing Industry consolidation Scrutiny around social media Impact of empowered patients/consumers Intensified focus on analytics/ROI/measurement Decreased impact of sales forces Regulatory changes Programs that go “beyond the pill” Evolution of EHRs Emphasis on specialty drugs/high-science categories Adopting a data-science culture More digital experimentation Seizing opportunities around cannabis Working from home Ongoing fallout from pandemic

Creative Samples